Clinical Trial Update: Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating niraparib as maintenance therapy in patients with advanced ovarian cancer in the neoadjuvant setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: The University of Hong Kong | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED